Until recently, physicians tended not to treat hyper-tension in older people. Opinion held that
high blood pressure was a useful adaptation to maintain flow in rigid arteriosclerotic arteries …

Background: Concern has been raised about the potential for adverse cognitive effects
associated with the use of calcium-channel blockers (CCBs) in older people. This study was …

Objective: Treating hypertension in those aged at least 80 years is now recommended;
however, the best antihypertensive to choose remains unexplored. Calcium channel blocker …

ognitive impairment, especially in its extreme manifesta-C tion of dementia, is of vital
importance to the patient and the geriatrician. It is a frequent complaint in office practice as …

The systolic hypertension in Europe (Syst-Eur) trial has been the only trial that has
suggested a protective effect of antihypertensive treatment on incidence of dementia. It is …

As a group, verapamil, diltiazem and dihydropyridines are commonly named calcium
channel blockers. Introduced into clinical medicine in the 1960s, they are among the most …

Calcium channel blockers (CCBs) are widely used for reducing blood pressure of
hypertensive patients. Recent reports document the beneficial effects of CCB for preventing …

Background Hypertension is a major risk factor for the development of stroke. It is well
known that lowering blood pressure decreases the risk of stroke in people with moderate to …

Background: Hypertension is prevalent in older adults. Hypertension has also been
associated with an increased risk of cognitive decline. However, evidence relating to the …

Hypertension is the most important modifiable risk factor for stroke. There is clear and ample
evidence of benefit for treating elderly hypertensive subjects up to the age of 80 with systolic …